🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

10123+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data

Showing 20 of 10123 recruiting trials

EARLY_Phase 1RecruitingNCT07313618

Safety and Efficacy of a Single Suprachoroidal Injection of JWK010 Gene Therapy in Subjects With Oculocutaneous Albinism Type 1 (OCA1)

👨‍⚕️ Fang Lu, Department of Ophthalmology, West China Hospital, Sichuan University📍 1 site📅 Started Dec 2025View details ↗
Phase 2RecruitingNCT07304739

Furmonertinib Combined With Intrathecal Chemotherapy and Stereotactic Radiotherapy (SRT) for EGFR-Mutated NSCLC Patients With Brain Parenchymal and Leptomeningeal Metastases

👨‍⚕️ Maobin Meng, Tianjin Medical University Cancer Institute and Hospital📍 3 sites📅 Started Dec 2025View details ↗
Phase 1RecruitingNCT07148050

Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells

👨‍⚕️ Colleen Annesley, MD, Seattle Children's Hospital📍 1 site📅 Started Dec 2025View details ↗
RecruitingNCT07243782

Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cosentyx®(Secukinumab) in Korea

👨‍⚕️ Novartis Pharmaceuticals, Novartis Pharmaceuticals📍 1 site📅 Started Dec 2025View details ↗
NARecruitingNCT07307560

High-Flow Nasal Cannula for Preventing Hypoxia During Sedated Endoscopy in High-Risk Obstructive Sleep Apnea Patients

🏥 Zhejiang University📍 3 sites📅 Started Dec 2025View details ↗
RecruitingNCT07280104

Infants With Primary Congenital Hypothyroidism and Development

🏥 Nigde Omer Halisdemir University📍 1 site📅 Started Dec 2025View details ↗
Phase 2RecruitingNCT07334912

AEF0217 in Participants With Down Syndrome

👨‍⚕️ Pier Vincenzo PIAZZA, MD, PhD, Aelis Farma📍 10 sites📅 Started Dec 2025View details ↗
Phase 1RecruitingNCT07203755

Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine

👨‍⚕️ Yanxia Wang, Henan Center for Disease Control and Prevention📍 1 site📅 Started Dec 2025View details ↗
Phase 1, PHASE2RecruitingNCT07135050

Phase 1/2 Study of MZ-1866, an AAV-9 Gene Therapy Delivered by Intracerebroventricular Injection to Participants With Pitt Hopkins Syndrome

🏥 Mahzi Therapeutics📍 3 sites📅 Started Dec 2025View details ↗
EARLY_Phase 1RecruitingNCT07120971

Metformin for Premature Infants With Bronchopulmonary Dysplasia

👨‍⚕️ G. Ganesh Konduri, MD, MS, Medical College of Wisconsin📍 1 site📅 Started Dec 2025View details ↗
NARecruitingNCT07479927

Telematic Cognitive Training and Mindfulness in Pediatric Patients After CAR-T Cell Therapy, Single Hematopoietic Allogeneic Transplant or Chemotherapy

🏥 Hospital Universitario La Paz📍 1 site📅 Started Dec 2025View details ↗
Phase 1RecruitingNCT07300241

Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

👨‍⚕️ Klaus Wagner, MD, PhD, Neomorph, Inc📍 7 sites📅 Started Dec 2025View details ↗
NAEnrolling by InvitationNCT06984887

Evaluation of New TB Diagnostic Tests (NATs) in Pakistan

🏥 Mercy Corps Pakistan📍 1 site📅 Started Dec 2025View details ↗
Phase 2RecruitingNCT07187778

Phase II Trial of Single Agent Belzutifan or Pembrolizumab Versus Combination as Neoadjuvant Therapy in Clear Cell Renal Cell Carcinoma (BLAZE)

👨‍⚕️ Eric Jonasch, MD, M.D. Anderson Cancer Center📍 1 site📅 Started Dec 2025View details ↗
Phase 3RecruitingNCT07225686

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy

👨‍⚕️ MD, Amgen📍 47 sites📅 Started Dec 2025View details ↗
NARecruitingNCT07220265

Impact of Phenylalanine Elevations on Brain and Cognition in Adult PKU Carriers

👨‍⚕️ Shawn Christ📍 1 site📅 Started Dec 2025View details ↗
Phase 1RecruitingNCT07444814

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

👨‍⚕️ Margaret C Dugan, MD, Whitehawk Therapeutics📍 12 sites📅 Started Dec 2025View details ↗
Phase 2RecruitingNCT06940661

Obinutuzumab for Remission Induction in Patients With Relapsing PR3-ANCA Granulomatosis With Polyangiitis

👨‍⚕️ Xavier PUECHAL, PhD, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris - Service de Médecine Interne, Centre de référence " Maladies systémiques et autoimmunes rares, en particulier Vascularites nécrosantes et Sclérodermies systémiques "📍 1 site📅 Started Dec 2025View details ↗
Phase 2RecruitingNCT07284420

ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod

🏥 argenx📍 5 sites📅 Started Dec 2025View details ↗
Phase 2RecruitingNCT07263919

Perioperative Cadonilimab Combined With Neoadjuvant Chemotherapy in Resectable Esophageal Squamous Cell Carcinoma (ESCC)

👨‍⚕️ Xiaolong Yan, The Second Affiliated Hospital of Air Force Medical University📍 1 site📅 Started Dec 2025View details ↗
← PreviousPage 32 of 507Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →